Literature DB >> 2185281

Guidelines on oral anticoagulation: second edition. British Society for Haematology. British Committee for Standards in Haematology. Haemostasis and Thrombosis Task Force.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2185281      PMCID: PMC502325          DOI: 10.1136/jcp.43.3.177

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


× No keyword cloud information.
  14 in total

1.  Venous thrombosis and pulmonary embolism. Their prevention by oral anticoagulants.

Authors:  S SEVITT
Journal:  Am J Med       Date:  1962-11       Impact factor: 4.965

Review 2.  Antithrombotic agents in coronary artery disease.

Authors:  L Resnekov; J Chediak; J Hirsh; H D Lewis
Journal:  Chest       Date:  1989-02       Impact factor: 9.410

Review 3.  Optimal therapeutic range for oral anticoagulants.

Authors:  J Hirsh; L Poller; D Deykin; M Levine; J E Dalen
Journal:  Chest       Date:  1989-02       Impact factor: 9.410

Review 4.  Antithrombotic therapy in mechanical and biological prosthetic heart valves and saphenous vein bypass grafts.

Authors:  P D Stein; A Kantrowitz
Journal:  Chest       Date:  1989-02       Impact factor: 9.410

Review 5.  Antithrombotic therapy for venous thromboembolic disease.

Authors:  T M Hyers; R D Hull; J G Weg
Journal:  Chest       Date:  1989-02       Impact factor: 9.410

6.  Oral anticoagulants controlled by the British comparative thromboplastin versus low-dose heparin in prophylaxis of deep vein thrombosis.

Authors:  D A Taberner; L Poller; R W Burslem; J B Jones
Journal:  Br Med J       Date:  1978-02-04

7.  Therapeutic control of anticoagulant treatment.

Authors:  B M Duxbury
Journal:  Br Med J (Clin Res Ed)       Date:  1982-03-06

8.  Calibration of reference thromboplastins and standardisation of the prothrombin time ratio.

Authors:  T B Kirkwood
Journal:  Thromb Haemost       Date:  1983-06-28       Impact factor: 5.249

9.  Two-step warfarin therapy. Prevention of postoperative venous thrombosis without excessive bleeding.

Authors:  C W Francis; V J Marder; C M Evarts; S Yaukoolbodi
Journal:  JAMA       Date:  1983-01-21       Impact factor: 56.272

10.  Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis.

Authors:  R Hull; J Hirsh; R Jay; C Carter; C England; M Gent; A G Turpie; D McLoughlin; P Dodd; M Thomas; G Raskob; P Ockelford
Journal:  N Engl J Med       Date:  1982-12-30       Impact factor: 91.245

View more
  9 in total

1.  Prediction of the international normalized ratio and maintenance dose during the initiation of warfarin therapy.

Authors:  B Vadher; D L Patterson; M Leaning
Journal:  Br J Clin Pharmacol       Date:  1999-07       Impact factor: 4.335

Review 2.  Therapeutic ranges for oral anticoagulation in different thromboembolic disorders.

Authors:  L Poller
Journal:  Ann Hematol       Date:  1992-02       Impact factor: 3.673

3.  The Safety of Laparoscopic Sleeve Gastrectomy in Patients Receiving Chronic Anticoagulation Therapy: A Case-Matched Study.

Authors:  Olivier Gerin; Lionel Rebibo; Abdennaceur Dhahri; Jean-Marc Regimbeau
Journal:  Obes Surg       Date:  2015-09       Impact factor: 4.129

4.  Suspected acute pulmonary embolism: a practical approach. British Thoracic Society, Standards of Care Committee.

Authors: 
Journal:  Thorax       Date:  1997-10       Impact factor: 9.139

5.  Self management of oral anticoagulation: randomised trial.

Authors:  D A Fitzmaurice; E T Murray; D McCahon; R Holder; J P Raftery; S Hussain; H Sandhar; F D R Hobbs
Journal:  BMJ       Date:  2005-10-10

6.  Evaluation of coagulant activity after mechanical heart valve replacement.

Authors:  Naoki Konagai; Norio Uchimura; Keita Nakamura; Tatsuhiko Kudo
Journal:  J Artif Organs       Date:  2006       Impact factor: 1.731

Review 7.  Therapeutic target values in oral anticoagulation--justification of Dutch policy and a warning against the so-called moderate-intensity regimens.

Authors:  E A Loeliger
Journal:  Ann Hematol       Date:  1992-02       Impact factor: 3.673

Review 8.  Drug treatment associated with heart valve replacement.

Authors:  D S Coulshed; M A Fitzpatrick; C H Lee
Journal:  Drugs       Date:  1995-06       Impact factor: 9.546

9.  Primary care anticoagulant management using near patient testing.

Authors:  M Daly; A W Murphy; C O'Hanlon; A Cosgrove; D McKeown; E Egan
Journal:  Ir J Med Sci       Date:  2003 Jan-Mar       Impact factor: 1.568

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.